Loading...

Bevacizumab for Patients with Recurrent Gliomas Presenting with a Gliomatosis Cerebri Growth Pattern

Bevacizumab has been shown to improve progression-free survival and neurologic function, but failed to improve overall survival in newly diagnosed glioblastoma and at first recurrence. Nonetheless, bevacizumab is widely used in patients with recurrent glioma. However, its use in patients with glioma...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Mol Sci
Main Authors: Burger, Michael C., Mildenberger, Iris C., Wagner, Marlies, Mittelbronn, Michel, Steinbach, Joachim P., Bähr, Oliver
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5412312/
https://ncbi.nlm.nih.gov/pubmed/28353668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18040726
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!